174 related articles for article (PubMed ID: 38096784)
1. Bacterial antigens unleash tumor-targeting immunity.
Boeck N; Trajanoski Z; Galluzzi L
Cell Host Microbe; 2023 Dec; 31(12):1945-1947. PubMed ID: 38096784
[TBL] [Abstract][Full Text] [Related]
2. Integrating tumor genomics into studies of the microbiome in colorectal cancer.
Burns MB; Blekhman R
Gut Microbes; 2019; 10(4):547-552. PubMed ID: 30556775
[TBL] [Abstract][Full Text] [Related]
3. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
4. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
Hou X; Zheng Z; Wei J; Zhao L
Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
[TBL] [Abstract][Full Text] [Related]
5. Impacts of MicroRNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer.
Xing J; Liao Y; Zhang H; Zhang W; Zhang Z; Zhang J; Wang D; Tang D
Front Cell Infect Microbiol; 2022; 12():804689. PubMed ID: 35493741
[TBL] [Abstract][Full Text] [Related]
6. Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer.
Gu M; Yin W; Zhang J; Yin J; Tang X; Ling J; Tang Z; Yin W; Wang X; Ni Q; Zhu Y; Chen T
Front Cell Infect Microbiol; 2023; 13():1119992. PubMed ID: 37265504
[TBL] [Abstract][Full Text] [Related]
7. Significance of the gut microbiome in multistep colorectal carcinogenesis.
Mizutani S; Yamada T; Yachida S
Cancer Sci; 2020 Mar; 111(3):766-773. PubMed ID: 31910311
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
[TBL] [Abstract][Full Text] [Related]
9. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
Jackson DN; Theiss AL
Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota-derived metabolites in CRC progression and causation.
Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
[TBL] [Abstract][Full Text] [Related]
11. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure.
Velikova T; Krastev B; Lozenov S; Gencheva R; Peshevska-Sekulovska M; Nikolaev G; Peruhova M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578709
[TBL] [Abstract][Full Text] [Related]
13. Strategies for the treatment of colorectal cancer caused by gut microbiota.
de Souza JB; Brelaz-de-Castro MCA; Cavalcanti IMF
Life Sci; 2022 Feb; 290():120202. PubMed ID: 34896161
[TBL] [Abstract][Full Text] [Related]
14. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa.
Lawrence GW; Begley M; Cotter PD; Guinane CM
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019270
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer: the facts in the case of the microbiota.
Clay SL; Fonseca-Pereira D; Garrett WS
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166235
[TBL] [Abstract][Full Text] [Related]
16. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
17. The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens.
Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
mSphere; 2023 Apr; 8(2):e0062622. PubMed ID: 36847529
[TBL] [Abstract][Full Text] [Related]
18. Leveraging explainable AI for gut microbiome-based colorectal cancer classification.
Rynazal R; Fujisawa K; Shiroma H; Salim F; Mizutani S; Shiba S; Yachida S; Yamada T
Genome Biol; 2023 Feb; 24(1):21. PubMed ID: 36759888
[TBL] [Abstract][Full Text] [Related]
19. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
20. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
